HMGB-1 was reported to predict the development of acute exacerbation (AE) appearing pathologically as diffuse alveolar damage, and ALI/ARDS and mortality after AE onset, in idiopathic interstitial pneumonia patients [31,32,33]. Here, HMGB1 is linked to idiopathic interstitial pneumonia.